JNJ dividend yield: 3.36%. IBM dividend yield: 3.06%. Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices. IBM is a Dividend Aristocrat with 28+ consecutive years of increases. After spinning off its managed infrastructure business as Kyndryl in 2021, IBM refocused on hybrid cloud and AI. Its Red Hat acquisition underpins a software-led business model with higher margins and more predictable revenue growth.
Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.
IBM is a Dividend Aristocrat with 28+ consecutive years of increases. After spinning off its managed infrastructure business as Kyndryl in 2021, IBM refocused on hybrid cloud and AI. Its Red Hat acquisition underpins a software-led business model with higher margins and more predictable revenue growth.
JNJ currently offers a 3.36% yield (4.96/share/year) while IBM offers 3.06% (6.68/share/year). JNJ provides higher current income. However, JNJ has grown its dividend faster (5.8% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in JNJ vs IBM earn per year?
With $10,000 invested today: JNJ pays approximately $336/year. IBM pays approximately $306/year. With DRIP reinvestment over 10 years, these grow to $828/year (JNJ) and $410/year (IBM).
Does JNJ or IBM pay monthly dividends?
JNJ pays quarterly dividends. IBM pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this JNJ vs IBM comparison by email
Save your analysis + get weekly dividend insights. Free forever.